Literature DB >> 4045470

N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme.

M E Truckenmiller, M A Namboodiri, M J Brownstein, J H Neale.   

Abstract

L-Aspartate N-acetyltransferase, a nervous system enzyme that mediates the synthesis of N-acetyl-L-aspartic acid, has been characterized. In the presence of acetyl-CoA, L-aspartate was acetylated 10-fold more efficiently than L-glutamate, and the acetylation of aspartylglutamate was not detectable. Within the nervous system, a 10-fold variation in the enzyme activity was observed, with the brainstem and spinal cord exhibiting the highest activity (10-15 pmol/min/mg tissue) and retina the lowest detectable activity (1-1.5 pmol/min/mg). No enzyme activity was detected in pituitary, heart, liver, or kidney. The enzyme activity was found to be membrane-associated and was solubilized by treatment with Triton X-100.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045470     DOI: 10.1111/j.1471-4159.1985.tb07240.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

2.  Quantification of N-acetyl-L-aspartic acid in urine by isotope dilution gas chromatography-mass spectrometry.

Authors:  R I Kelley; J N Stamas
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  N-acetylaspartic acid (NAA) and N-acetylaspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid.

Authors:  K F Faull; R Rafie; N Pascoe; L Marsh; A Pfefferbaum
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

4.  N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy.

Authors:  L Hagenfeldt; I Bollgren; N Venizelos
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla.

Authors:  Rosane Gomez; Kevin L Behar; June Watzl; Stuart A Weinzimer; Barbara Gulanski; Gerard Sanacora; Julia Koretski; Elizabeth Guidone; Lihong Jiang; Ismene L Petrakis; Brian Pittman; John H Krystal; Graeme F Mason
Journal:  Biol Psychiatry       Date:  2011-08-19       Impact factor: 13.382

Review 6.  Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.

Authors:  M H Baslow; T R Resnik
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

7.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat.

Authors:  Jianfeng Wang; Paola Leone; Gusheng Wu; Jeremy S Francis; Hong Li; Mohit Raja Jain; Tadao Serikawa; Robert W Ledeen
Journal:  Neurochem Res       Date:  2008-05-14       Impact factor: 3.996

9.  N-acetyl-L-glutamate in brain: assay, levels, and regional and subcellular distribution.

Authors:  E Alonso; M A García-Pérez; J Bueso; V Rubio
Journal:  Neurochem Res       Date:  1991-07       Impact factor: 3.996

10.  Measuring N-acetylaspartate synthesis in vivo using proton magnetic resonance spectroscopy.

Authors:  Su Xu; Jehoon Yang; Jun Shen
Journal:  J Neurosci Methods       Date:  2008-04-10       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.